Item 2.02 - Results of Operations and Financial Condition: Bath & Body Works is disclosing financial results as of August 26, 2026 Item 7.01 - Regulation FD Disclosure: The company is furnishing additional disclosure information via Exhibit 99.1 Filing Date and Timing: This 8-K was filed on August 26, 2026, reporting on events occurring on the same date Non-Filed Status: The information is being…

Our analysis rates this filing CAUTIOUS. Bath & Body Works presents an elevated concern profile driven by three material negative signals that outweigh positive tactical improvements. The most critical concern is the dramatic 73-89% EPS decline guidance for Q3 2026, which represents a material…

Concern level: HIGH (6.8/10). Key factors: One critical high-severity risk identified: Q3 2026 earnings guidance shows 73-89% EPS decline versus prior year quarter (severity 7/10), indicating material seasonal or operational challenges not fully explained by management; Tariff refund dependency masking operational weakness: $80 million one-time benefit inflated Q2 adjusted EPS by approximately…

Notable risk changes: Tariff refund of $80 million in Q2 2026 artificially inflated adjusted EPS by approximately 50% ($0.31 to $0.62), masking underlying operational weakness and creating risk of earnings disappointment if refunds cease; Q3 2026 earnings guidance shows 73-89% decline in EPS versus prior year quarter, indicating material seasonal or operational challenges ahead that management has not fully…

Q2 net sales exceeded guidance; Q2 adjusted EPS exceeded guidance; Direct channel returned to growth for first time since 2021.

The model predicts BBWI will outperform the S&P 500 by about 0.1% over 30 days. This is model analysis for research, not investment advice.